Brief: Trevi Therapeutics Announces Pricing Of $100 Million Underwritten Offering Of Common Stock
04/06/2025 03:16
June 3 (Reuters) - Trevi Therapeutics Inc TRVI.O: TREVI THERAPEUTICS ANNOUNCES PRICING OF $100 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK TREVI THERAPEUTICS INC - PRICING OF OFFERING OF 17,400,000 SHARES OF ITS COMMON STOCK AT $5.75 PER SHARE Source text: ID:nPn86CkSya Further company coverage: TRVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million